| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, M Akdis, I Andrä, F Annunziato, ... European journal of immunology 47 (10), 1584-1797, 2017 | 660 | 2017 |
| Natural killer cell immunotypes related to COVID-19 disease severity C Maucourant, I Filipovic, A Ponzetta, S Aleman, M Cornillet, L Hertwig, ... Science immunology 5 (50), eabd6832, 2020 | 428 | 2020 |
| Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells Q Hammer, T Rückert, EM Borst, J Dunst, A Haubner, P Durek, F Heinrich, ... Nature immunology 19 (5), 453-463, 2018 | 416 | 2018 |
| Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2Chi Natural Killer Cells M Luetke-Eversloh, Q Hammer, P Durek, K Nordström, G Gasparoni, ... PLoS pathogens 10 (10), e1004441, 2014 | 267 | 2014 |
| Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ... Cell reports 15 (5), 1088-1099, 2016 | 239 | 2016 |
| Natural killer cell specificity for viral infections Q Hammer, T Rückert, C Romagnani Nature immunology 19 (8), 800-808, 2018 | 215 | 2018 |
| TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells T Sekine, A Perez-Potti, S Nguyen, JB Gorin, VH Wu, E Gostick, ... Science immunology 5 (49), eaba7918, 2020 | 172 | 2020 |
| Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells ML Saetersmoen, Q Hammer, B Valamehr, DS Kaufman, KJ Malmberg Seminars in immunopathology 41, 59-68, 2019 | 150 | 2019 |
| Remodeling of secretory lysosomes during education tunes functional potential in NK cells JP Goodridge, B Jacobs, ML Saetersmoen, D Clement, Q Hammer, ... Nature communications 10 (1), 514, 2019 | 131 | 2019 |
| Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help J Ni, O Hölsken, M Miller, Q Hammer, M Luetke-Eversloh, C Romagnani, ... Oncoimmunology 5 (9), e1219009, 2016 | 97 | 2016 |
| About training and memory: NK-cell adaptation to viral infections Q Hammer, C Romagnani Advances in immunology 133, 171-207, 2017 | 75 | 2017 |
| Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets C Wu, DA Espinoza, SJ Koelle, D Yang, L Truitt, H Schlums, BA Lafont, ... Science immunology 3 (29), 2018 | 52 | 2018 |
| SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells Q Hammer, J Dunst, W Christ, F Picarazzi, M Wendorff, P Momayyezi, ... Cell reports 38 (10), 2022 | 45 | 2022 |
| NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells M Babic, C Dimitropoulos, Q Hammer, C Stehle, F Heinrich, ... Journal of Experimental Medicine 217 (8), 2020 | 32 | 2020 |
| Adaptive single-KIR+ NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia A Haroun-Izquierdo, M Vincenti, H Netskar, H Van Ooijen, B Zhang, ... Journal for Immunotherapy of Cancer 10 (11), 2022 | 30 | 2022 |
| NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals A Cuapio, C Boulouis, I Filipovic, D Wullimann, T Kammann, T Parrot, ... Molecular Medicine 28 (1), 20, 2022 | 28 | 2022 |
| Adaptive natural killer cells integrate interleukin-18 during target-cell encounter Q Hammer, T Rückert, J Dunst, C Romagnani Frontiers in immunology 8, 323365, 2018 | 23 | 2018 |
| OMIP‐039: Detection and analysis of human adaptive NKG2C+ natural killer cells Q Hammer, C Romagnani Cytometry Part A 91 (10), 997-1000, 2017 | 20 | 2017 |
| Extent of cytomegalovirus replication in the human host depends on variations of the HLA-E/UL40 axis H Vietzen, T Rückert, S Hartenberger, C Honsig, P Jaksch, S Geleff, ... MBio 12 (2), 10.1128/mbio. 02996-20, 2021 | 19 | 2021 |
| Engineering immune-evasive allogeneic cellular immunotherapies KE Martin, Q Hammer, K Perica, M Sadelain, KJ Malmberg Nature Reviews Immunology, 1-14, 2024 | 11 | 2024 |
Timo RückertCharité - Universitätsmedizin BerlinПотвърден имейл адрес: charite.de
